The announcement by Winner Medical Group, Inc that its CEO and Chairman offered to acquire the remaining shares of Winner Medical Group, Inc for $4.30 per NASDAQ:WWIN share prompted an investigation for investors in Winner Medical Group, Inc (NASDAQ:WWIN) shares concerning whether the offer to acquire Winner Medical Group, Inc and the buyout process are unfair to investors in NASDAQ:WWIN shares.
Investors who purchased shares of Winner Medical Group, Inc (NASDAQ:WWIN) prior to April 2, 2012 and currently hold (any of ) those NASDAQ:WWIN shares have certain options and should contact the Shareholders Foundation at mail(at)shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigations by law firms concern whether certain officers and directors of Winner Medical Group, Inc breach their fiduciary duties owed to NASDAQ:WWIN investors in connection with the proposed acquisition.
On Monday, April 2, 2012, Winner Medical Group Inc. (Nasdaq: WWIN) announced that its board of directors has received a preliminary, non-binding proposal from its chairman and chief executive officer, Mr. Jianquan Li (“Mr. Li”). Under the terms of the proposal, Mr. Li intends to acquire all of the outstanding shares of Winner Medical Group’s common stock not currently owned by him and his wife at a proposed price of $4.30 per share in cash as part of a going private transaction.
However, NASDAQ:WWIN shares traded in July 2011 as high as $4.89 and in April 2011 as high as $5.23, thus well above the current offer. In addition at least one analyst has set the high target price for NASDAQ:WWIN shares at $5.50 per share, thus well above the current offer. Winner Medical Group, Inc also performed well for its investors in the past. Winner Medical Group reported that is Total Revenue rose from $85.51million for a 12months period ending on Sept. 30, 2008 to $149.90million for a 12months period ending on Sept. 30, 2011 and its Net Income over the same time periods increased from $5.07million to $11.54million.
Furthermore, Mr. Li and his wife currently beneficially own approximately 73.95% of Winner Medical Group’s common stock.
Therefore the investigation for NASDAQ:WWIN investors concerns whether the Winner Medical Group Board of Directors fail to undertake an adequate sales process, fail to adequately shop the company before entering into any transaction, fail to negotiate the best price to maximize shareholder value, and fail to act in the shareholders’ best interests in connection with the proposed sale.
Those who are current investors in Winner Medical Group, Inc (NASDAQ:WWIN) and purchased their Winner Medical Group shares prior to the announcement, have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego